PharmaCann Inc. (“PharmaCann”), the largest privately held, vertically integrated cannabis company in the United States, announced its Verilife dispensaries in Albany and Bronx, New York, are now offering whole flower under the “matter” brand as of today, October 26th, and whole flower will be available in its Amherst and Liverpool locations tomorrow, October 27th.
“We are pleased to bring patients the first whole flower for sale in the State of New York across multiple locations,” said Brett Novey, CEO of PharmaCann. “This exciting milestone builds on our history as the first medical cannabis license holder in New York. We commend Governor Hochul, her administration, and the Office of Cannabis Management for their commitment to expanding offerings to New York Medical patients.”
Verilife’s initial whole flower strain offering in New York is the “matter” branded Pineapple Super Silver Haze with several additional strains being introduced over the coming weeks.
As the largest provider to the medical cannabis community in New York, PharmaCann is currently expanding its cultivation and processing operations located in Hamptonburgh. In the upcoming months, pending regulatory approval, Verilife plans to double its number of retail locations, for a total of eight New York dispensaries.
PharmaCann Inc. operates its dispensaries under the name Verilife. Verilife is committed to helping people feel better and live better by dispelling outdated perceptions associated with cannabis and encouraging a new appreciation of its many benefits. For more information, please visit www.verilife.com.
PharmaCann is the largest privately held and vertically integrated cannabis companies, providing safe, reliable, and high-quality cannabis products to people in both the medical and adult-use markets. The PharmaCann geographic footprint includes dispensaries and cultivation and processing operations in six states. For more information about PharmaCann, please visit: PharmaCann.com.
Tel: 312-667-6260 ext. 322019